In addition, although overweight and obesity is markedly more common, some individuals with advanced HF like HFrEF are also cachexic (Rossignol et al., 2015) and may therefore not benefit from the weight-reducing effect of GLP-1 RAs
In a 72-week study, participants experienced an average weight loss of 15-21% when taking different doses of Tirzepatide (5 mg, 10 mg, or 15 mg)
That academic pipeline raises the quality floor for GLP-1 providers across the Triangle
Conn syndrome Conn syndrome is increasingly diagnosed in older people, especially those with treatment-resistant hypertension
[DOI] [PMC free article] [PubMed] 37.Wang L, Wang W, Kaelber DC, Xu R, Berger NA
Paul Jarrod Frank, who observed the phenomenon among patients using weight-loss drugs